Table of Contents
Chapter 1.Global Inhalation Anesthesia Market Definition and Research Assumptions
1.1.Research Objective
1.2.Market Definition
1.3.Research Assumptions
1.3.1.Inclusion & Exclusion
1.3.2.Limitations
1.3.3.Supply Side Analysis
1.3.3.1.Availability
1.3.3.2.Infrastructure
1.3.3.3.Regulatory Environment
1.3.3.4.Market Competition
1.3.3.5.Economic Viability (Consumer's Perspective)
1.3.4.Demand Side Analysis
1.3.4.1.Regulatory frameworks
1.3.4.2.Technological Advancements
1.3.4.3.Environmental Considerations
1.3.4.4.Consumer Awareness & Acceptance
1.4.Estimation Methodology
1.5.Years Considered for the Study
1.6.Currency Conversion Rates
Chapter 2.Executive Summary
2.1.Global Inhalation Anesthesia Market Size & Forecast (2022- 2032)
2.2.Regional Summary
2.3.Segmental Summary
2.3.1.By Type
2.3.2.By End-user
2.4.Key Trends
2.5.Recession Impact
2.6.Analyst Recommendation & Conclusion
Chapter 3.Global Inhalation Anesthesia Market Dynamics
3.1.Market Drivers
3.2.Market Challenges
3.3.Market Opportunities
Chapter 4.Global Inhalation Anesthesia Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter's 5 Force Model
4.1.7.Porter's 5 Force Impact Analysis
4.2.PESTEL Analysis
4.2.1.Political
4.2.2.Economical
4.2.3.Social
4.2.4.Technological
4.2.5.Environmental
4.2.6.Legal
4.3.Top investment opportunity
4.4.Top winning strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion
Chapter 5.Global Inhalation Anesthesia Market Size & Forecasts by Type 2022-2032
5.1.Desflurane
5.2.Sevoflurane
5.3.Isoflurane
5.4.Other Types
Chapter 6.Global Inhalation Anesthesia Market Size & Forecasts by End-user 2022-2032
6.1.Hospital
6.2.Ambulatory Surgical Centers
6.3.Other End Users
Chapter 7.Global Inhalation Anesthesia Market Size & Forecasts by Region 2022-2032
7.1.North America Inhalation Anesthesia Market
7.1.1.U.S. Inhalation Anesthesia Market
7.1.1.1. Type breakdown size & forecasts, 2022-2032
7.1.1.2.End-user breakdown size & forecasts, 2022-2032
7.1.2.Canada Inhalation Anesthesia Market
7.2.Europe Inhalation Anesthesia Market
7.2.1.U.K. Inhalation Anesthesia Market
7.2.2.Germany Inhalation Anesthesia Market
7.2.3.France Inhalation Anesthesia Market
7.2.4.Spain Inhalation Anesthesia Market
7.2.5.Italy Inhalation Anesthesia Market
7.2.6.Rest of Europe Inhalation Anesthesia Market
7.3.Asia-Pacific Inhalation Anesthesia Market
7.3.1.China Inhalation Anesthesia Market
7.3.2.India Inhalation Anesthesia Market
7.3.3.Japan Inhalation Anesthesia Market
7.3.4.Australia Inhalation Anesthesia Market
7.3.5.South Korea Inhalation Anesthesia Market
7.3.6.Rest of Asia Pacific Inhalation Anesthesia Market
7.4.Latin America Inhalation Anesthesia Market
7.4.1.Brazil Inhalation Anesthesia Market
7.4.2.Mexico Inhalation Anesthesia Market
7.4.3.Rest of Latin America Inhalation Anesthesia Market
7.5.Middle East & Africa Inhalation Anesthesia Market
7.5.1. Saudi Arabia Inhalation Anesthesia Market
7.5.2. South Africa Inhalation Anesthesia Market
7.5.3.Rest of Middle East & Africa Inhalation Anesthesia Market
Chapter 8.Competitive Intelligence
8.1.Key Company SWOT Analysis
8.2.Top Market Strategies
8.3.Company Profiles
8.3.1. Merck KGaA
8.3.1.1.Key Information
8.3.1.2.Overview
8.3.1.3.Financial (Subject to Data Availability)
8.3.1.4.Product Summary
8.3.1.5.Market Strategies
8.3.2. AbbVie Inc.
8.3.3.Baxter International Inc.
8.3.4.Fresenius Kabi AG (Fresenius SE& Co. KGaA
8.3.5.Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
8.3.6.Hikma Pharmaceuticals PLC
8.3.7.Jiangsu Hengrui Medicine Co. Ltd
8.3.8.Lunan Pharmaceutical Group Co. Ltd
8.3.9.Piramal Enterprises Limited
8.3.10.Troikaa Pharmaceuticals Ltd
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.2.Research Attributes